Comment by
Analystika on Nov 11, 2020 5:08pm
I'll be interested to see analysis from the broader community on the results. But certainly achieving positive ebitda in their slowest quarter is a great sign. Did anyone listen to the call this am? What was managements thoughts in the future growth rates/outlook in light of the Pfizer announcement?